Vertex Pharmaceuticals Shaping the Future of Advanced Therapies in Saudi Arabia

Vertex Pharmaceuticals is a global biotechnology company dedicated to transforming the lives of people with serious diseases through cutting-edge scientific innovation. Since 1989, Vertex has developed approved medicines that address the underlying causes of chronic, life-shortening genetic conditions such as cystic fibrosis, sickle cell disease, and transfusion-dependent beta thalassemia, while advancing a robust pipeline targeting other serious diseases, including APOL1-mediated kidney disease, type 1 diabetes, and acute and neuropathic pain.

In 2023, Vertex strengthened its presence in the Middle East by establishing its GCC regional headquarters in Riyadh, serving six countries. This strategic hub focuses on delivering breakthrough therapies from Vertex’s global research and development programs to patients across the region, underscoring the company’s commitment to improving lives and advancing healthcare in the GCC. At the Global Health Exhibition, Vertex Pharmaceuticals will showcase its ongoing collaboration with Saudi health authorities to advance innovation and improve care for people living with serious blood disorders in the Kingdom.